Medical progress - Papillary and follicular thyroid carcinoma

[1] American Association of Clinical Endocrinologists Clinical practice guidelines for the management of thyroid carcinoma, 1997, ENDOCR PRACT, V3, P60

[2] [Anonymous], 1992, ATLAS TUMOR PATHOL

[3] THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) : 806 - 814

[4] FACTORS AFFECTING SUPPRESSION OF ENDOGENOUS THYROTROPIN SECRETION BY THYROXINE TREATMENT - RETROSPECTIVE ANALYSIS IN ATHYREOTIC AND GOITROUS PATIENTS [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (04) : 849 - 855

[5] Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) : 2006 - 2009

[6] High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation [J]. ONCOGENE, 1997, 15 (11) : 1263 - 1273

[7] Brierley JD, 1997, CANCER, V79, P2414

[8] PROGNOSTIC INDEX FOR THYROID-CARCINOMA - STUDY OF THE EORTC-THYROID-CANCER-COOPERATIVE-GROUP [J]. EUROPEAN JOURNAL OF CANCER, 1979, 15 (08) : 1033 - 1041

[9] CADY B, 1988, SURGERY, V104, P947

[10] CASARA D, 1993, J NUCL MED, V34, P1626

[1] American Association of Clinical Endocrinologists Clinical practice guidelines for the management of thyroid carcinoma, 1997, ENDOCR PRACT, V3, P60

[2] [Anonymous], 1992, ATLAS TUMOR PATHOL

[3] THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) : 806 - 814

[4] FACTORS AFFECTING SUPPRESSION OF ENDOGENOUS THYROTROPIN SECRETION BY THYROXINE TREATMENT - RETROSPECTIVE ANALYSIS IN ATHYREOTIC AND GOITROUS PATIENTS [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (04) : 849 - 855

[5] Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) : 2006 - 2009

[6] High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation [J]. ONCOGENE, 1997, 15 (11) : 1263 - 1273

[7] Brierley JD, 1997, CANCER, V79, P2414

[8] PROGNOSTIC INDEX FOR THYROID-CARCINOMA - STUDY OF THE EORTC-THYROID-CANCER-COOPERATIVE-GROUP [J]. EUROPEAN JOURNAL OF CANCER, 1979, 15 (08) : 1033 - 1041

[9] CADY B, 1988, SURGERY, V104, P947

[10] CASARA D, 1993, J NUCL MED, V34, P1626